A proteomics view of the molecular mechanisms and biomarkers of glaucomatous neurodegeneration

Publication date: Available online 5 February 2013
Source:Progress in Retinal and Eye Research
Author(s): Gülgün Tezel
Despite improving understanding of glaucoma, key molecular players of neurodegeneration that can be targeted for treatment of glaucoma, or molecular biomarkers that can be useful for clinical testing, remain unclear. Proteomics technology offers (Read more...)

Full Story →